Fiona Stavros

Sr. VP Pre-Clinical Affairs at Rénibus Therapeutics

Fiona Stavros has worked in the pharmaceutical industry since 1988. Fiona began their career at Synbiotics Corporation as a Manager in 1988. Fiona then moved to Immunopharmaceutics Inc. in 1991, where they held the role of Manager. In 1995, they joined Encysive Pharmaceuticals Inc.- a Pfizer company - as the Sr. Director of Nonclinical Development. In 2009, they became a Nonclinical Drug Development and Toxicology Consultant at Jackrabbit Consulting LLC. From 2010 to 2017, they worked at ZS Pharma, Inc. as VP of Nonclinical Development, overseeing all areas related to the safety evaluation and development of NCEs. Finally, they joined Rénibus Therapeutics Inc. in 2017 as the Sr. VP of Pre-Clinical Affairs.

Fiona Stavros completed their BSc Hon and PhD in Pharmacology from The University of Edinburgh between 1971 and 1981. Fiona then completed a Post Doc in Pharmacology from King's College London between 1981 and 1982.

Location

Poway, United States

Links


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Rénibus Therapeutics

Rénibus Therapeutics is a biotech company dedicated to transforming the cardio-renal disease treatment paradigm by focusing on the prevention, treatment, and diagnostic testing of kidney disease.


Industries

Employees

51-200

Links